Assessment of glycaemic control and risk of hypoglycaemia for two basal-bolus algorithms in hospitalised patients with diabetes mellitus type 2

被引：0
|
作者：
Mader, J. K. [1 ]
Neubauer, K. M. [1 ]
Schaupp, L. [1 ]
Aberer, F. [1 ]
Donsa, K. [2 ]
Augustin, T. [2 ]
Spat, S. [2 ]
Hoell, B. [2 ]
Beck, P. [2 ]
Plank, J. [1 ]
Pieber, T. R. [1 ]
机构：
[1] Med Univ Graz, Graz, Austria
[2] Joanneum Res GmbH, HLTH, Graz, Austria
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
979
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [41] Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
    van Brunt, Kate
    Curtis, Bradley
    Ivanyi, Tibor
    Balogh, Elemer
    Chalkiadaki, Corina
    MacLachlan, Sharon
    Neasham, David
    Raluy-Callado, Mireia
    DIABETES THERAPY, 2016, 7 (04) : 793 - 807
  • [42] GlucoTab- Software based Work Process- and Decision Support for secure Glycemic Control by Basal-Bolus Insulin Treatment for hospitalised Patients with Type-2-Diabetes
    Neubauer, Katharina Maria
    Mader, Julia Katharina
    Hoell, Bernhard
    Schaupp, Lukas
    Beck, Peter
    Spat, Stephan
    Aberer, Felix
    Schwagerle, Gerd
    Plank, Johannes
    Buttinger, Martina
    Pieber, Thomas Rudolf
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S182 - S182
  • [43] Continuous Glucose Monitoring in hospitalized Patients with Type 2 Diabetes during Basal-Bolus Insulin Therapy
    Schaupp, Lukas
    Neubauer, Katharina
    Mader, Julia
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S15 - S15
  • [44] Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
    Kathryn M. Pfeiffer
    Amaury Basse
    Xin Ying Lee
    Laura Tesler Waldman
    Diabetes Therapy, 2018, 9 : 1931 - 1944
  • [45] Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
    Pfeiffer, Kathryn M.
    Basse, Amaury
    Lee, Xin Ying
    Waldman, Laura Tesler
    DIABETES THERAPY, 2018, 9 (05) : 1931 - 1944
  • [46] Achieving postprandial glucose control with lixisenatide improves glycaemic control in patients with type 2 diabetes mellitus on basal insulin
    Paranjape, S.
    Stager, W.
    Berria, R.
    Leiter, L. A.
    DIABETOLOGIA, 2015, 58 : S383 - S383
  • [47] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
    Ruhnau, KJ
    Schneider, K
    Schweitzer, MA
    DIABETES, 2005, 54 : A518 - A518
  • [48] Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control
    Can, Ayten
    Bekpinar, Seldag
    Gurdol, Figen
    Tutuncu, Yildiz
    Unlucerci, Yesim
    Dinccag, Nevin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (03) : E61 - E64
  • [49] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
    Ruhnau, KJ
    Schneider, K
    Schweitzer, MA
    DIABETOLOGIA, 2005, 48 : A303 - A303
  • [50] Comparison of canagliflozin and liraglutide as a replacement for bolus insulin in type 2 diabetes patients well-controlled by basal-bolus insulin
    Kumashiro, N.
    Ando, Y.
    Shigiyama, F.
    Igarashi, H.
    Yoshikawa, F.
    Uchino, H.
    Yoshino, H.
    Miyagi, M.
    Ikehara, K.
    Hirose, T.
    DIABETOLOGIA, 2018, 61 : S126 - S126
12345